6.
Elferink M, Visser O, Wiggers T, Otter R, Tollenaar R, Langendijk J
. Prognostic factors for locoregional recurrences in colon cancer. Ann Surg Oncol. 2012; 19(7):2203-11.
DOI: 10.1245/s10434-011-2183-4.
View
7.
Berger A, Sigurdson E, Levoyer T, Hanlon A, Mayer R, Macdonald J
. Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol. 2005; 23(34):8706-12.
DOI: 10.1200/JCO.2005.02.8852.
View
8.
Fortea-Sanchis C, Martinez-Ramos D, Escrig-Sos J
. CUSUM charts in the quality control of colon cancer lymph node analysis: a population-registry study. World J Surg Oncol. 2018; 16(1):230.
PMC: 6267835.
DOI: 10.1186/s12957-018-1533-0.
View
9.
Bockelman C, Engelmann B, Kaprio T, Hansen T, Glimelius B
. Risk of recurrence in patients with colon cancer stage II and III: a systematic review and meta-analysis of recent literature. Acta Oncol. 2014; 54(1):5-16.
DOI: 10.3109/0284186X.2014.975839.
View
10.
Aghili M, Izadi S, Madani H, Mortazavi H
. Clinical and pathological evaluation of patients with early and late recurrence of colorectal cancer. Asia Pac J Clin Oncol. 2010; 6(1):35-41.
DOI: 10.1111/j.1743-7563.2010.01275.x.
View
11.
Bouvier A, Launoy G, Bouvier V, Rollot F, Manfredi S, Faivre J
. Incidence and patterns of late recurrences in colon cancer patients. Int J Cancer. 2015; 137(9):2133-8.
DOI: 10.1002/ijc.29578.
View
12.
Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, Jemal A
. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6):394-424.
DOI: 10.3322/caac.21492.
View
13.
Hatano S, Ishida H, Ishibashi K, Kumamoto K, Haga N, Miura I
. Identification of risk factors for recurrence in high-risk stage II colon cancer. Int Surg. 2013; 98(2):114-21.
PMC: 3723177.
DOI: 10.9738/CC131.
View
14.
Tsai H, Chu K, Huang Y, Su Y, Wu J, Kuo C
. Predictive factors of early relapse in UICC stage I-III colorectal cancer patients after curative resection. J Surg Oncol. 2009; 100(8):736-43.
DOI: 10.1002/jso.21404.
View
15.
Tsikitis V, Larson D, Huebner M, Lohse C, Thompson P
. Predictors of recurrence free survival for patients with stage II and III colon cancer. BMC Cancer. 2014; 14:336.
PMC: 4029910.
DOI: 10.1186/1471-2407-14-336.
View
16.
Ryuk J, Choi G, Park J, Kim H, Park S, Yoon G
. Predictive factors and the prognosis of recurrence of colorectal cancer within 2 years after curative resection. Ann Surg Treat Res. 2014; 86(3):143-51.
PMC: 3994626.
DOI: 10.4174/astr.2014.86.3.143.
View
17.
Cho Y, Chun H, Yun H, Lee W, Yun S, Lee W
. Clinical and pathologic evaluation of patients with recurrence of colorectal cancer five or more years after curative resection. Dis Colon Rectum. 2007; 50(8):1204-10.
DOI: 10.1007/s10350-007-0247-0.
View
18.
Haggar F, Boushey R
. Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. Clin Colon Rectal Surg. 2010; 22(4):191-7.
PMC: 2796096.
DOI: 10.1055/s-0029-1242458.
View
19.
Osterman E, Glimelius B
. Recurrence Risk After Up-to-Date Colon Cancer Staging, Surgery, and Pathology: Analysis of the Entire Swedish Population. Dis Colon Rectum. 2018; 61(9):1016-1025.
DOI: 10.1097/DCR.0000000000001158.
View
20.
Steele S, Park G, Johnson E, Martin M, Stojadinovic A, Maykel J
. The impact of age on colorectal cancer incidence, treatment, and outcomes in an equal-access health care system. Dis Colon Rectum. 2014; 57(3):303-10.
DOI: 10.1097/DCR.0b013e3182a586e7.
View